PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31201586-4	2019	In vitro, garcinol reduced the expression of pro-inflammatory cytokines, such as IL-6 and tumor necrosis factor alpha (TNF-alpha).	garcinol	10-18	tumor necrosis factor	Mus musculus	90-117	
31201586-4	2019	In vitro, garcinol reduced the expression of pro-inflammatory cytokines, such as IL-6 and tumor necrosis factor alpha (TNF-alpha).	garcinol	10-18	tumor necrosis factor	Mus musculus	119-128	
29016683-8	2017	Garcinol treatment reduced CCL2 and TNF-alpha expression, as demonstrated on cultured vSMCs and leukocytes.	garcinol	0-8	tumor necrosis factor	Mus musculus	36-45	
30925687-5	2019	Furthermore, garcinol suppressed nuclear factor-kappaB (NF-kappaB) and pro-inflammatory cytokines such as tumor necrosis factor-alpha and IL-6, whereas it preserved the nuclear expression of nuclear factor erythroid-derived 2-like factor 2 (Nrf2) and levels of Nrf2-dependent antioxidants including heme oxygense-1, catalase, superoxide dismutase 1, and NAD(P)H:quinone oxidoreductase 1.	garcinol	13-21	tumor necrosis factor	Mus musculus	106-133	
27122221-5	2016	The results of the current study demonstrated that garcinol promoted LPS-induced expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in RAW264.7 cells.	garcinol	51-59	tumor necrosis factor	Mus musculus	95-122	
27122221-5	2016	The results of the current study demonstrated that garcinol promoted LPS-induced expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in RAW264.7 cells.	garcinol	51-59	tumor necrosis factor	Mus musculus	124-133	
27122221-7	2016	Additionally, treatment with garcinol enhanced LPS-induced expression of TNF-alpha and IL-6, exacerbated LPS-induced lung injury, increased LPS-induced elevation of plasma alanine aminotransferase and blood urea nitrogen, and reduced the survival rate of LPS-challenged mice.	garcinol	29-37	tumor necrosis factor	Mus musculus	73-82